+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

From
From
From
From
GMP Principles in Vaccine Manufacturing (December 13-14, 2027) - Product Thumbnail Image

GMP Principles in Vaccine Manufacturing (December 13-14, 2027)

  • Training
  • December 2027
  • 2 Days
  • Global
Biosimilars (September 20-21, 2027) - Product Thumbnail Image

Biosimilars (September 20-21, 2027)

  • Training
  • September 2027
  • 2 Days
  • Global
GMP Principles in Vaccine Manufacturing (June 15-16, 2027) - Product Thumbnail Image

GMP Principles in Vaccine Manufacturing (June 15-16, 2027)

  • Training
  • June 2027
  • 2 Days
  • Global
Biosimilars (March 15-16, 2027) - Product Thumbnail Image

Biosimilars (March 15-16, 2027)

  • Training
  • March 2027
  • 2 Days
  • Global
GMP Principles in Vaccine Manufacturing (December 8-9, 2026) - Product Thumbnail Image

GMP Principles in Vaccine Manufacturing (December 8-9, 2026)

  • Training
  • December 2026
  • 2 Days
  • Global
Biosimilars (October 1-2, 2026) - Product Thumbnail Image

Biosimilars (October 1-2, 2026)

  • Training
  • October 2026
  • 2 Days
  • Global
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more